Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 202 new people
  • 262 new organizations
  • 270 new photos
  • 1098 job history records for people in our database
  • 627 education records for people in our database
  • 1073 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 9 new people through the revolving door
  • 164 new policy reports
  • 47 new trips to our privately funded travel database
  • 252 new personal financial disclosures
  • 8371 new press releases
  • 19 new town halls
  • 70 new hearings
» More from our DevBlog

Caught Our Eye

Sen. Thom Tillis adviser heads to Gilead

Posted by Keturah Hetrick on March 9, 2022

One of Sen. Thom Tillis's (R-N.C.) first Hill hires has left for Gilead Sciences.

Bill Bode joined the biopharmaceutical giant this month as director of government affairs. Gilead pumped nearly $8.2 million into its federal lobbying program last year. That makes it the country's eighth largest pharmaceutical lobbying group, according to OpenSecrets.

Bode started in Tillis's office as a legislative correspondent shortly after the senator took office in 2015 and worked his way up to become a senior policy adviser. He is concurrently working and pursuing a law degree at American University's Washington College of Law.

Subjects: American University Washington College of Law; Sen. Thom Tillis (R-NC); Gilead Sciences Inc.; William Adams Bode (Bill)

See full Caught Our Eye archive

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com